Test marketing a new migraine drug with a “sensational” new approach

Over 28 million people in the U.S. experience migraine and over 52% remain undiagnosed. In response, Pfizer launched a three-phased test-marketing campaign targeting diagnosed patients, undiagnosed migraine sufferers and the public at large. The campaign highlight: The Relpax Serenity Spa, a 10-city public awareness campaign that dramatized how Relpax restored normal sensory experiences lost during a migraine attack.


Public Awareness Campaign

View “Serenity Spa” Event Video >>

Mini Brochure
Public Awareness Website (sample pages)

Patient Marketing
Doctor’s Office Display
Patient Guide